SUNPHARMANSEOffline
SUN PHARMA INDS. · INE044A01036 · Large Cap · #13- Prev close
- 1,773.40
- Open
- —
- High
- —
- Low
- —
- Volume
- —
- Mkt cap (6-mo avg)
- ₹4,21,858 cr
Loading minute bars…
NSE 1-minute bars from our CandleApi gateway (history from 21 Jul 2026); longer timeframes are built from them. Prices not adjusted for corporate actions.
SUNPHARMA is 9% below its 52-week high, above its 200-day average, behind Healthcare by 6.6 pts over 3 months — a Large Cap company, #13 by market cap.NSE prices to 05 Nov 2026 · a description of the data, not advice
Overview
What the data says, line by line
A description, never a buy or sell word · tap a line for its detail
How big is it?
six-month average market cap
Our own six-month average, computed the way AMFI computes it; the published classification is on the market cap page.
Did buyers take delivery?
latest session · 2026-11-05
Price & trend
Returns
to 05 Nov 2026
| Period | Stock | vs Nifty 500 | vs its industry |
|---|---|---|---|
| 1 week | +3.9% | −1.9 pts | — |
| 1 month | +1.4% | −3.1 pts | −2.4 pts |
| 3 months | −5.7% | −3.6 pts | −6.6 pts |
| 6 months | −1.1% | −1.5 pts | −10.9 pts |
| 1 year | +7.4% | +10.2 pts | — |
Industry: Healthcare (Nifty 500 classification) · rank 25 of 44 over 3 months. Points = the stock’s return minus the benchmark’s. Prices adjusted for splits and bonuses.
Averages & movement
F&O
Where option open interest clusters
expiry 23 Nov 2026 · 18 days
Near expiry. Max pain is the strike at which option buyers’ total payout would be least; strikes with the most open interest are where positions cluster.
Volatility & expected move
Futures build-up, by day
all expiries' OI · today: long build-up · 3 sessions
| Session | Build-up | Future price | OI, all expiries |
|---|---|---|---|
| 05 Nov 2026 | long build-up | +3.1% | +8.7% |
| 04 Nov 2026 | long build-up | +0.2% | +5.0% |
| 03 Nov 2026 | long build-up | +0.5% | +5.1% |
| 02 Nov 2026 | short build-up | −1.1% | +8.6% |
| 30 Oct 2026 | short covering | +1.2% | −4.3% |
| 29 Oct 2026 | short covering | +0.3% | −0.7% |
| 28 Oct 2026 | long unwinding | −0.0% | −0.7% |
| 27 Oct 2026 | short covering | +0.8% | −1.5% |
| 26 Oct 2026 | short build-up | −0.1% | +2.9% |
| 23 Oct 2026 | short build-up | −0.5% | +1.5% |
From the exchanges’ F&O bhavcopies. A description of positions, not a forecast. Open interest across the market.
Ownership
Who owns the company
% of all shares, by quarter
| Group | Dec 25 | Mar 26 | Jun 26 | Sep 26 |
|---|---|---|---|---|
| Promoters | 54.5% | 54.5% | 54.5% | 52.7% −1.8 |
| FPI | 16.1% | 15.9% −0.2 | 14.5% −1.4 | 14.4% −0.2 |
| Mutual funds | 12.1% | 12.0% −0.1 | 12.8% +0.9 | 13.0% +0.2 |
| Other DII | 8.6% | 9.0% +0.4 | 9.2% +0.2 | 9.3% |
| Individuals | 5.4% | 5.3% −0.1 | 5.5% +0.2 | 6.7% +1.2 |
| Others | 3.3% | 3.3% | 3.4% +0.2 | 4.0% +0.5 |
From the company’s quarterly shareholding pattern. Changes in percentage points against the quarter before. No quarters are on record between Sep 2022 and Jun 2025.
Promoter pledge
Sep 26
Holders
Sep 26
Indian passive funds’ stake
2026-06-30
8,50,13,911 shares held by Indian passive mutual-fund schemes. A floor, not the total — foreign ETFs, insurance and EPFO are not counted.
Which funds bought and sold
mutual funds · quarter ended 2026-06-30
| Fund | Shares | Change | Did |
|---|---|---|---|
| Kotak Flexi Cap Fund(G)Active | +31,80,200 | +16061.6% | bought |
| HSBC Large & Mid Cap Fund-Reg(G)Active | +4,82,921 | +1955.1% | bought |
| Nippon India Small Cap Fund(G)Active | +9,47,551 | +1806.6% | bought |
| Bajaj Finserv Flexi Cap Fund-Reg(G)Active | −6,67,792 | −87.0% | sold |
| Bajaj Finserv Large Cap Fund-Reg(G)Active | −2,67,167 | −86.3% | sold |
| LIC MF Arbitrage Fund-Reg(G)Active | −13,300 | −84.4% | sold |
Ranked by how much each fund changed its own position, not by size of trade. Every fund here still holds the company — one that sold out entirely leaves no record to find.
Mutual-fund schemes, month by month
fund houses’ own monthly portfolios
| Month | Schemes | Bought new | Added | Cut | Sold out | Shares held | Value |
|---|---|---|---|---|---|---|---|
| Sep 26 | 431 | 15 | 129 | 100 | 8 | +2.3% | ₹51,175 cr |
| Aug 26 | 424 | 42 | 144 | 81 | 41 | +0.3% | ₹54,553 cr |
| Jul 26 | 423 | 23 | 102 | 125 | 20 | −3.7% | ₹54,632 cr |
| Jun 26 | 420 | 23 | 143 | 85 | 24 | −0.5% | ₹53,101 cr |
| May 26 | 421 | 11 | 137 | 72 | 11 | +2.3% | ₹51,558 cr |
| Apr 26 | 420 | 22 | 173 | 91 | 19 | +4.6% | ₹50,666 cr |
Each month against the one before, counting only the fund houses that reported both (45 houses in Sep 26); a split or bonus is divided out first. “Partial” = fewer than five houses reported yet.
Fund ownership is a quarterly disclosure and counts Indian passive schemes only.
Results
Results
Events & filings
Nifty 50 history
from NSE press releases
In the Nifty 50 since before 2014.
No change and no near miss recorded for SUNPHARMA in NSE’s review releases since 2014. NSE names near misses in its releases from 2024 on.
Disclosures & deals
last six months · NSE filings
- Credit rating14 Oct 2026
- Scheme / acquisition09 Sept 2026
- Credit rating05 Aug 2026
- Board outcome31 Jul 2026
- Scheme / acquisition22 Jun 2026
- Board outcome25 May 2026
- Block deal: SELL24 Jun 2026
- Block deal: BUY24 Jun 2026
Latest shown; 9 in six months on all disclosures.
SUNPHARMA: only ratings, pledges, insider and takeover disclosures, buybacks, schemes, board outcomes and deals are listed. All deals.
Corporate actions
full published history
| Earlier | Dividend | ₹5 | Final | 07 Jul 2026 | 07 Jul 2026 |
| Earlier | Dividend | ₹11 | Interim | 05 Feb 2026 | 05 Feb 2026 |
| Earlier | Dividend | ₹5.5 | Final | 07 Jul 2025 | 07 Jul 2025 |
| Earlier | Dividend | ₹10.5 | Interim | 06 Feb 2025 | 06 Feb 2025 |
| Earlier | Dividend | ₹5 | Final | 12 Jul 2024 | 12 Jul 2024 |
| Earlier | Dividend | ₹8.5 | Interim | 09 Feb 2024 | 09 Feb 2024 |
| Earlier | Dividend | ₹4 | Final | 28 Jul 2023 | 28 Jul 2023 |
| Earlier | Dividend | ₹7.5 | Interim | 08 Feb 2023 | 08 Feb 2023 |
| Earlier | Dividend | ₹3 | Final | 19 Aug 2022 | 22 Aug 2022 |
| Earlier | Dividend | ₹7 | Interim | 09 Feb 2022 | 10 Feb 2022 |
12 shown. A falling price on an ex-date is not a loss: a dividend leaves the share as cash and a bonus multiplies the shares held.
Market capitalisation is our own six-month average, computed the way AMFI computes it; the published classification is on the market cap page. Fund ownership is a quarterly disclosure and counts Indian passive schemes only. Nothing here is advice, a recommendation, or a view on the company.